Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.1
-14.11%
20%
—
44.56%
Every year
—
5 Years
Score5.1
Net Growth-14.11%
Net Trend20%
Net Income Consistency—
Rev Growth44.56%
Rev TrendEvery year
Revenue Consistency—
Elevance Health Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 79.23B to $ 199.12B and net income grew from $ 2.56B to $ 5.66B. Revenue increased in every one of those 10 years; net income in 4.
Across Elevance Health Inc's full reported history, from 2001 to 2025, revenue grew from $ 10.44B to $ 199.12B and net income grew from $ 342M to $ 5.66B. Revenue increased in 92% of the years measured; net income in 48%.
Elevance Health Inc currently holds a 20-year HDB Score of 5.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 399.14 | — |
1 Year2025-08-12 | $ 286.46 | 39.33% |
5 Years2021-08-12 | $ 342.15 | 16.66% |
10 Years2016-08-12 | $ 113.34 | 252.18% |
20 Years2006-08-11 | $ 59.19 | 6x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 399.14 | $ 286.46 | $ 342.15 | $ 113.34 | $ 59.19 |
| Return | — | 39.33% | 16.66% | 252.18% | 6x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 200.41B | $ 5.24B | $ 35.56B |
| 2025 | $ 199.12B | $ 5.66B | $ 9.49B |
| 2024 | $ 176.81B | $ 5.98B | $ 8.28B |
| 2023 | $ 171.34B | $ 5.98B | $ 6.52B |
| 2022 | $ 156.59B | $ 5.89B | $ 7.38B |
| 2021 | $ 138.63B | $ 6.10B | $ 4.88B |
| 2020 | $ 121.86B | $ 4.57B | $ 5.74B |
| 2019 | $ 104.21B | $ 4.80B | $ 4.93B |
| 2018 | $ 92.10B | $ 3.75B | $ 3.93B |
| 2017 | $ 90.03B | $ 3.84B | $ 3.60B |
| 2016 | $ 84.97B | $ 2.46B | $ 4.07B |
| 2015 | $ 79.23B | $ 2.56B | $ 2.11B |
| 2014 | $ 73.92B | $ 2.56B | $ 2.15B |
| 2013 | $ 71.12B | $ 2.65B | $ 1.58B |
| 2012 | $ 61.53B | $ 2.65B | $ 2.47B |
| 2011 | $ 60.80B | $ 2.64B | $ 2.20B |
| 2010 | $ 58.84B | $ 2.88B | $ 1.78B |
| 2009 | $ 61.64B | $ 4.74B | $ 4.81B |
| 2008 | $ 62.45B | $ 2.49B | $ 2.18B |
| 2007 | $ 61.39B | $ 3.34B | $ 2.76B |
| 2006 | $ 57.00B | $ 3.09B | $ 2.60B |
| 2005 | $ 45.15B | $ 2.46B | $ 19.52B |
| 2004 | $ 20.81B | $ 960M | $ 15.04B |
| 2003 | $ 16.75B | $ 774M | $ 7.37B |
| 2002 | $ 13.25B | $ 549M | $ 6.64B |
| IPO2001 | $ 10.44B | $ 342M | $ 4.47B |
Explore beyond ELV
You're looking at Elevance Health Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
